These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 35224605)

  • 61. COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barré Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    Jeong HS; Chun BC
    PLoS One; 2024; 19(2):e0297902. PubMed ID: 38381729
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373).
    Fix J; Christopher Mast T; Smith K; Baker N
    Vaccine; 2024 Apr; 42(9):2161-2165. PubMed ID: 38494410
    [TBL] [Abstract][Full Text] [Related]  

  • 63. BNT162b2 Vaccine-Associated Myo/Pericarditis in Adolescents: A Stratified Risk-Benefit Analysis.
    Krug A; Stevenson J; Høeg TB
    Eur J Clin Invest; 2022 May; 52(5):e13759. PubMed ID: 35156705
    [TBL] [Abstract][Full Text] [Related]  

  • 64. COVID-19, Myocarditis and Pericarditis.
    Fairweather D; Beetler DJ; Di Florio DN; Musigk N; Heidecker B; Cooper LT
    Circ Res; 2023 May; 132(10):1302-1319. PubMed ID: 37167363
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology].
    Sinagra G; Porcari A; Merlo M; Barillà F; Basso C; Ciccone MM; Curcio A; Mancone M; Mercuro G; Muscoli S; Nodari S; Pedrinelli R; Spaccarotella C; Filardi PP; Indolfi C
    G Ital Cardiol (Rome); 2021 Nov; 22(11):894-899. PubMed ID: 34709228
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine.
    Park S; You J
    J Korean Med Sci; 2022 Apr; 37(16):e131. PubMed ID: 35470603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prominent J Waves and Ventricular Fibrillation Caused by Myocarditis and Pericarditis After BNT162b2 mRNA COVID-19 Vaccination.
    Uesako H; Fujikawa H; Hashimoto S; Wakabayashi T
    Can J Cardiol; 2022 Jun; 38(6):844-847. PubMed ID: 35151782
    [No Abstract]   [Full Text] [Related]  

  • 68. Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12-17 years.
    Guo BQ; Li HB; Yang LQ
    Vaccine; 2023 Jun; 41(28):4067-4080. PubMed ID: 37246067
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Incidence rates of myocarditis and pericarditis within 30 days following homologous and heterologous BNT162b2 vaccinations in individuals 5-40 years of age.
    Kumwichar P; Chongsuvivatwong V; Vasoppakarn S; Atthakul N; Nakhonsri V; Ngamphiw C; Khunkham P; Janpoung W; Tongsima S
    Vaccine; 2024 Feb; 42(4):844-852. PubMed ID: 38246843
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myocarditis and Pericarditis After Vaccination for COVID-19.
    Diaz GA; Parsons GT; Gering SK; Meier AR; Hutchinson IV; Robicsek A
    JAMA; 2021 Sep; 326(12):1210-1212. PubMed ID: 34347001
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Myocarditis and pericarditis risk with mRNA COVID-19 vaccination compared to unvaccinated individuals: A retrospective cohort study in a Spanish Tertiary Hospital.
    Elizalde MU; Eguinoa FJG; de Las Huertas AGL; Jiménez-González M; Ramírez E
    Biomed Pharmacother; 2024 Feb; 171():116181. PubMed ID: 38262150
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.
    Haaf P; Kuster GM; Mueller C; Berger CT; Monney P; Burger P; Stämpfli SF; Attenhofer Jost CH; Zellweger MJ; Osswald S; Donner BC; Koestner SC; Tanner FC
    Swiss Med Wkly; 2021 Oct; 151():w30087. PubMed ID: 34668687
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020-October 2021).
    Lee ASY; Balakrishnan IDD; Khoo CY; Ng CT; Loh JKX; Chan LL; Teo LLY; Sim DKL
    Heart Lung Circ; 2022 Jun; 31(6):757-765. PubMed ID: 35227610
    [TBL] [Abstract][Full Text] [Related]  

  • 74. COVID-19 vaccination-related myocarditis: a Korean nationwide study.
    Cho JY; Kim KH; Lee N; Cho SH; Kim SY; Kim EK; Park JH; Choi EY; Choi JO; Park H; Kim HY; Yoon HJ; Ahn Y; Jeong MH; Cho JG
    Eur Heart J; 2023 Jun; 44(24):2234-2243. PubMed ID: 37264895
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Myocarditis With COVID-19 mRNA Vaccines.
    Bozkurt B; Kamat I; Hotez PJ
    Circulation; 2021 Aug; 144(6):471-484. PubMed ID: 34281357
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients.
    Naveed Z; Li J; Naus M; Velásquez García HA; Wilton J; Janjua NZ;
    Int J Infect Dis; 2023 Jun; 131():75-78. PubMed ID: 36967038
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination.
    Weintraub ES; Oster ME; Klein NP
    JAMA Netw Open; 2022 Jun; 5(6):e2218512. PubMed ID: 35749119
    [No Abstract]   [Full Text] [Related]  

  • 78. Myopericarditis following COVID-19 vaccination in adolescent triplets.
    Wong JW; Bock E; Kee WS; Anderson AJ; Kothari D; Tarca AJ
    Cardiol Young; 2023 Nov; 33(11):2379-2383. PubMed ID: 37154289
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database.
    Lee S; Jo H; Lee H; Lee H; Lee J; Kim HJ; Kang J; Jacob L; Smith L; Rahmati M; López Sánchez GF; Dragioti E; Jeon H; Cho JM; Choi Y; Park J; Woo S; Yon DK
    J Med Virol; 2024 Jun; 96(6):e29693. PubMed ID: 38859751
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidence Rates and Clinical Characteristics of Patients With Confirmed Myocarditis or Pericarditis Following COVID-19 mRNA Vaccination: Experience of the Veterans Health Administration Through 9 October 2022.
    Luo J; Hur K; Salone C; Huang N; Burk M; Pandey L; Thakkar B; Donahue M; Cunningham F
    Open Forum Infect Dis; 2023 Jul; 10(7):ofad268. PubMed ID: 37469619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.